logo
#

Latest news with #Danishgovernment

Medical journal rejects Kennedy's call for retraction of vaccine study
Medical journal rejects Kennedy's call for retraction of vaccine study

TimesLIVE

timea day ago

  • Health
  • TimesLIVE

Medical journal rejects Kennedy's call for retraction of vaccine study

An influential US medical journal is rejecting a call from US health secretary Robert F Kennedy Jnr to retract a large Danish study that found aluminium ingredients in vaccines do not increase health risks for children, the journal's editor told Reuters. Kennedy has long promoted doubts about vaccines' safety and efficacy and as health secretary has upended the federal government's process for recommending immunisation. A recent media report said he has been considering whether to initiate a review of shots that contain aluminium, which he said are linked to autoimmune diseases and allergies. The study, funded by the Danish government and published in July in the Annals of Internal Medicine, analysed nationwide registry data for more than 1.2-million children over more than two decades. It did not find evidence that exposure to aluminium in vaccines had caused an increased risk for autoimmune, atopic or allergic or neurodevelopmental disorders. The work is by far the best available evidence on the question of the safety of aluminium in vaccines, said Adam Finn, a childhood vaccination expert in the UK and paediatrician at the University of Bristol who was not involved in the study. "It's solid, [a] massive dataset and high-quality data," he said.

Exclusive-Medical journal rejects Kennedy's call for retraction of vaccine study
Exclusive-Medical journal rejects Kennedy's call for retraction of vaccine study

Yahoo

time2 days ago

  • Health
  • Yahoo

Exclusive-Medical journal rejects Kennedy's call for retraction of vaccine study

By Michael Erman and Jennifer Rigby (Reuters) -An influential U.S. medical journal is rejecting a call from Health Secretary Robert F. Kennedy Jr. to retract a large Danish study that found that aluminum ingredients in vaccines do not increase health risks for children, the journal's editor told Reuters. Kennedy has long promoted doubts about vaccines' safety and efficacy, and as health secretary has upended the federal government's process for recommending immunization. A recent media report said he has been considering whether to initiate a review of shots that contain aluminum, which he says are linked to autoimmune diseases and allergies. The study, which was funded by the Danish government and published in July in the Annals of Internal Medicine, analyzed nationwide registry data for more than 1.2 million children over more than two decades. It did not find evidence that exposure to aluminum in vaccines had caused an increased risk for autoimmune, atopic or allergic, or neurodevelopmental disorders. The work is by far the best available evidence on the question of the safety of aluminum in vaccines, said Adam Finn, a childhood vaccination expert in the UK and pediatrician at the University of Bristol, who was not involved in the study. "It's solid, (a) massive dataset and high-quality data," he said. Kennedy described the research as "a deceitful propaganda stunt by the pharmaceutical industry," and said the scientists who authored it had "meticulously designed it not to find harm" in a detailed Aug. 1 opinion piece on TrialSite News, an independent website focused on clinical research. He called on the journal to "immediately retract" the study. "I see no reason for retraction," Dr. Christine Laine, editor in chief of the Annals and a professor of medicine at Thomas Jefferson University, said in an interview. The journal plans to respond to criticism the article has received on its website, Laine said, but it does not intend to respond directly to Kennedy's piece, which was not submitted to the Annals. The lead author of the study, Anders Peter Hviid, head of the epidemiology research department at the Statens Serum Institut in Denmark, defended the work in a response post to TrialSite. He wrote that none of the critiques put forward by Kennedy were substantive and he categorically denied any deceit as implied by the secretary. "I am used to controversy around vaccine safety studies - especially those that relate to autism, but I have not been targeted by a political figurehead in this way before," Hviid said in an emailed response to Reuters. "I have confidence in our work and in our ability to reply to the critiques of our study." Kennedy had a number of critiques, including the lack of a control group, that the study deliberately excluded different groups of children to avoid showing a link between aluminum and childhood health conditions - including those with the highest levels of exposure - and that it did not include the raw data. Hviid responded to the criticisms on TrialSite. He said some of the points were related to study design choices that were reasonable to discuss but refuted others, including that the study was designed not to find a link. In fact he said, its design was based on a study led by Matthew Daley, a pediatrician at Kaiser Permanente Colorado, which did show a link, and which Kennedy cited in his article. There was no control group because in Denmark, only 2% of children are unvaccinated, which is too small for meaningful comparison, Hviid added. The data is available for researchers to analyze, but individual-level data is not released under Danish law, he said. Other prominent vaccine skeptics including those at the antivaccine organization Kennedy previously ran, Children's Health Defense, have similarly criticized the study on the Annals site. TrialSite staff defended the study for its scale, data transparency and funding while acknowledging the limitations of its design, a view seconded by some outside scientists. Laine said that while some of the issues Kennedy raised in his article may underscore acceptable limitations of the study, "they do not invalidate what they found, and there's no evidence of scientific misconduct." An HHS spokesman said the department had "no further comment than what the secretary said."

Novo Nordisk Owner Buys Microsoft Quantum Computer With Denmark
Novo Nordisk Owner Buys Microsoft Quantum Computer With Denmark

Bloomberg

time17-07-2025

  • Business
  • Bloomberg

Novo Nordisk Owner Buys Microsoft Quantum Computer With Denmark

The foundation behind Novo Nordisk A/S and the Danish government will invest €80 million ($93 million) in a Microsoft-powered quantum computer to boost technological development in the Nordic region. The computer, to be named Magne, will be made available to companies and researchers to develop products in sectors such as chemical, pharmaceutical, logistics and finance, and is due to take on its first tasks by early 2027. The Novo Nordisk Foundation and Denmark's Export and Investment Fund will each invest €40 million, according to a joint statement Thursday.

Air France-KLM to take majority control of Scandinavian airline SAS
Air France-KLM to take majority control of Scandinavian airline SAS

Euronews

time04-07-2025

  • Business
  • Euronews

Air France-KLM to take majority control of Scandinavian airline SAS

Air France-KLM said on Friday that it plans to increase its stake in Scandinavian airline SAS to 60.5%, up from around 20% currently. The additional shares will be acquired from Castlelake and Lind Invest, for an amount that will be determined by SAS's financial performance at closing. The sale is expected to be completed in the second half of 2026, subject to regulatory approval. The European Commission is likely to scrutinise the merger with care to ensure that it doesn't threaten fair competition. The Commission has already shown some opposition to airline consolidation. A merger between Ryanair and Aer Lingus was blocked on several occasions, while IAG abandoned plans to take over Air Europa due to expectations that the deal wouldn't receive the regulatory green light. Despite this, airlines in Europe continue to seek consolidation options in order to compete with overseas rivals, particularly from the US and the Middle East. Lufthansa, for example, has recently taken a stake in ITA Airways and airBaltic. 'As global interest in Scandinavia continues to grow, we believe this consolidation strengthens SAS' ability to connect Scandinavia with the world — and the world with Scandinavia — by positioning Copenhagen as our global hub for the region, while continuing to uphold strong and strategic operations in both Oslo and Stockholm,' said Anko van der Werff, president and CEO of SAS. Benjamin Smith, CEO of Air France-KLM, said: 'Following their successful restructuring, SAS has delivered impressive performance, and we are confident that the airline's potential will continue to grow through deeper integration within the Air France-KLM Group. This operation would benefit our customers and all Scandinavians who would enjoy enhanced connectivity.' Air France-KLM took an initial stake in SAS in 2023 as the struggling Scandinavian airline underwent a two-year restructuring process following its bankruptcy filing. The Danish government also holds a 26.4% stake in SAS and will retain its board seats if the sale to the Franco-Dutch carrier goes through. SAS has a fleet of 138 aircraft, carried more than 25 million passengers last year, and flies to over 130 destinations.

Saildrone Closes $60M Financing to Bring Maritime Autonomy to Europe
Saildrone Closes $60M Financing to Bring Maritime Autonomy to Europe

Business Wire

time13-05-2025

  • Business
  • Business Wire

Saildrone Closes $60M Financing to Bring Maritime Autonomy to Europe

COPENHAGEN, Denmark--(BUSINESS WIRE)-- Saildrone, the global leader in maritime autonomy, today announced the closing of a $60 million investment round led by EIFO, the Export and Investment Fund of Denmark. The investment will be used to bring Saildrone technology to Europe to address the urgent need for maritime security for critical infrastructure and wider defense applications. "Our goal is to provide 24/7, year-round coverage for all critical infrastructure within the Baltic and North Sea, safeguarding these highly valuable installations for current and future generations." – Saildrone founder and CEO Richard Jenkins Share The Baltic, North Sea, and European Arctic waters are currently facing unprecedented threats, and the need for persistent maritime domain awareness has never been greater. Saildrone's extreme endurance unmanned surface vehicles utilize sophisticated sensors, combined with proprietary AI algorithms, to give a full picture of the maritime environment above and below the sea surface. 'I am thrilled to partner with EIFO and the Danish government to establish Saildrone's European headquarters in Copenhagen, Denmark,' said Richard Jenkins, Saildrone's founder and CEO. 'Denmark's unique geographic and political position at the heart of northern Europe makes it the perfect place to establish our European headquarters and operational hub. Working initially with the Danish Armed Forces, we plan to roll out Saildrone's maritime intelligence services to multiple NATO countries during the course of the year. Our goal is to provide 24/7, year-round coverage for all critical infrastructure within the Baltic and North Sea, safeguarding these highly valuable installations for current and future generations.' In addition to EIFO, other participants in the round included existing investors Lux Capital, Washington Harbor Partners, Crowley, and Academy Securities, joined by new investors Pinegrove, BZH Capital, What If Ventures, and Calm Ventures. 'We are thrilled to invest in Saildrone and subsequently that Denmark has been chosen as the center for Saildrone's European activities. Saildrone is a leading company in a rapidly growing market, and gaining access to this technology can become critical for both Denmark's and Europe's security. We expect Saildrone will have an impact on both the Danish defense industry and the Danish challenges with surveillance in the Arctic and counteracting sabotage in Danish waters—at a fraction of the cost of a patrol ship,' said Peder Lundquist, CEO of EIFO. Saildrone will deploy the first four Saildrone Voyagers in the Baltic Sea in June 2025, under contract to the Danish Armed Forces. About Saildrone Saildrone is a maritime defense and oceanographic survey company creating a paradigm shift in how navies, governments, and commercial organizations obtain the real-time, accurate data required to monitor the maritime domain. Powered primarily by renewable wind and solar energy, Saildrone's fleet of unmanned surface vehicles (USVs) provides long-duration operations measured in months, not days. Saildrone USVs carry sophisticated sensors combined with proprietary AI algorithms to give a full picture of the maritime environment above and below the sea surface, supporting border protection, critical infrastructure security, and hydrographic survey. Saildrone has sailed more than 2,000,000 nautical miles from the High North to the Southern Ocean and spent over 50,000 days at sea in the harshest ocean conditions on the planet.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store